Maximum Daily Dose of Coreg for Hypertension
The maximum daily dose of Coreg (carvedilol) for hypertension is 50 mg per day, administered as 25 mg twice daily. 1
FDA-Approved Dosing for Hypertension
According to the FDA drug label, the dosing algorithm for hypertension is 1:
- Starting dose: 6.25 mg twice daily
- First titration (after 7-14 days if tolerated): 12.5 mg twice daily
- Maximum dose (after another 7-14 days if needed): 25 mg twice daily
- Total maximum daily dose: 50 mg per day
The full antihypertensive effect is typically seen within 7-14 days of each dose adjustment.
Key Dosing Considerations
Take with food: Carvedilol should always be taken with food to slow absorption and reduce orthostatic effects 1.
Monitoring for tolerance: Use standing systolic blood pressure measured approximately 1 hour after dosing as a guide for tolerance during uptitration 1. This is critical because carvedilol's alpha-blocking properties can cause orthostatic hypotension, particularly during dose escalation.
Combination therapy: When combined with diuretics, expect additive effects and exaggerated orthostatic responses 1. This is particularly relevant since major hypertension guidelines recommend combination therapy as initial treatment for most patients with confirmed hypertension 2, 3.
Clinical Context from Guidelines
While the FDA label establishes 50 mg/day as the maximum dose, it's important to note that beta-blockers are not recommended as first-line agents for hypertension unless compelling indications exist (such as ischemic heart disease, heart failure with reduced ejection fraction, or need for heart rate control) 2, 3. The 2017 ACC/AHA guidelines specifically list carvedilol's usual dose range as 12.5-50 mg daily, administered twice daily 2.
Contraindication in Severe Hepatic Impairment
Do not use carvedilol in patients with severe hepatic impairment 1. Due to extensive hepatic metabolism, even standard doses can cause severe toxicity in cirrhotic patients, with case reports of cardiogenic shock occurring at just 25 mg in patients with cirrhosis 4. No specific dose adjustments are provided for mild-to-moderate hepatic impairment in the FDA label, but extreme caution and slow uptitration are warranted.
Common Pitfall
The most common error is exceeding 50 mg total daily dose (25 mg twice daily) for hypertension. While higher doses up to 50 mg twice daily (100 mg/day total) are used in heart failure patients weighing over 85 kg 1, this does not apply to hypertension treatment where the maximum remains 50 mg/day total.